过去一年中添加的文章，按日期排序
DOACs or warfarin use in morbidly obese patients (BMI> 40 kg/m2) on anticoagulant therapy?: a systematic review and meta-analysis
M Sagris, N Ktenopoulos, K Pamporis… - European Heart …, 2023 - academic.oup.com
209 天前 - … use of direct oral anticoagulants (DOACs) for morbidly obese … > 40 kg/m2 and atrial
fibrillation (AF) or venous … firstly, the non-superiority of Warfarin compared to DOAC use, and …
fibrillation (AF) or venous … firstly, the non-superiority of Warfarin compared to DOAC use, and …